Fundraising Fox
/Companies
Sign in

Tremeau Pharmaceuticals

Cambridge, US · Founded 2016 · Delaware corporation · 1 employees on LinkedIn · 1 known investors

Find your way into Tremeau Pharmaceuticals

Each arrow is one introduction. Sign up to fill in the first one.

2 people can intro you to Mark

Ask Christoph Broja to introduce you to Mark Corrigan

You →Christoph · together at Tremeau Pharmaceuticals →Mark

Sign up to find every way you can get introduced to Tremeau Pharmaceuticals

  • Your email: who you already know at Tremeau Pharmaceuticals, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Tremeau Pharmaceuticals team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Tremeau develops non-opioid pain therapies for patient populations with high unmet medical needs. The company focuses on treatments for people living with pain.

BiotechHealthtech

Founders & leadership

Tremeau Pharmaceuticals was founded in 2016 by Bradford C. Sippy.

BC
Bradford C. SippyFounder
BE
Benjamin EnersonExecutive
MCMark Corrigan
Mark CorriganExecutiveMark Corrigan has held board and executive roles including CEO and Executive Chairman at research, clinical, and commercial-stage pharmaceutical companies, with experience in clinical research, translational medicine, and regulatory affairs.

Investors · 1

Gurnet Point Capitalreported

How we know: funding news · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

$5.2M disclosed across 1 of 2 rounds · 2016–2018

  • Undisclosed amountfirst equity roundFeb 2018
    Source ↗
▶$5.2MraisedFeb 2018 · 59 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin EnersonExecutive Officer
  • Mark CorriganExecutive Officer
  • Bradford C. SippyExecutive Officer, Director
Offering amount
$5.2M
Amount sold
$5.2M
Minimum investment
$10K
First sale
Oct 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Tremeau Pharmaceuticals do?
Tremeau develops non-opioid pain therapies for patient populations with high unmet medical needs. The company focuses on treatments for people living with pain.
Who founded Tremeau Pharmaceuticals?
Tremeau Pharmaceuticals was founded by Bradford C. Sippy in 2016.
Who are Tremeau Pharmaceuticals's investors?
Tremeau Pharmaceuticals's investors include Gurnet Point Capital.
How much funding has Tremeau Pharmaceuticals raised?
Tremeau Pharmaceuticals has disclosed $5.2M raised across 1 of its 2 known rounds.
Where is Tremeau Pharmaceuticals headquartered?
Tremeau Pharmaceuticals is headquartered in Cambridge, US.